Author

Ina Oehme

Observed names: I Oehme, I. Oehme, Oehme I., Oehme, Ina

Institutions: German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, Hopp Children's Cancer Center Heidelberg, Deutsches Konsortium für Translationale Krebsforschung

Observed institutions: German Cancer Research Center, University of Cologne, University of Toronto, Heidelberg University, Ghent University Hospital, Hospital for Sick Children, University Hospital Heidelberg, National Institute of Infectious Diseases, National Center for Tumor Diseases, Hopp Children's Cancer Center Heidelberg, Essen University Hospital, Georg Speyer Haus, Deutsches Konsortium für Translationale Krebsforschung, Stiftung Universitätsmedizin Essen, University of Duisburg-Essen, University of Göttingen

ORCID: 0000-0002-0827-2356

Observed ORCID: 0000-0002-0827-2356

OpenAlex ID: A5004020500

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

2016 · Daniel J Klionsky, Kotb Abdelmohsen, et al. · Autophagy · 5,856

PDF

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1

2021 · Daniel J. Klionsky, Amal Kamal Abdel-Aziz, et al. · Autophagy · 2,608

PDF

HDAC family: What are the cancer relevant targets?

2008 · Olaf Witt, Hedwig E. Deubzer, et al. · Cancer Letters · 1,056

Histone Deacetylase 8 in Neuroblastoma Tumorigenesis

2008 · Ina Oehme, Hedwig E. Deubzer, et al. · Clinical Cancer Research · 394

DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats

2017 · David Brocks, Christopher R Schmidt, et al. · Nature Genetics · 336

HDAC8: a multifaceted target for therapeutic interventions

2015 · Alokta Chakrabarti, Ina Oehme, et al. · Trends in Pharmacological Sciences · 274

PDF

Histone deacetylase 10 promotes autophagy-mediated cell survival

2013 · Ina Oehme, Jan-Peter Linke, et al. · Proceedings of the National Academy of Sciences · 220

HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth

2010 · Till Milde, Ina Oehme, et al. · Clinical Cancer Research · 193

Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation

2015 · I Rettig, E Koeneke, et al. · Cell Death and Disease · 180

PDF

Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells

2013 · Nathalie Fiegler, Sonja Textor, et al. · Blood · 134

HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment

2012 · Till Milde, Marco Lodrini, et al. · Journal of Neuro-Oncology · 131

Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors

2015 · Johanna Senger, Jelena Melesina, et al. · Journal of Medicinal Chemistry · 112

HDAC11 is a novel drug target in carcinomas

2012 · Hedwig E. Deubzer, Marie C. Schier, et al. · International Journal of Cancer · 110

Targeting Histone Deacetylase 8 as a Therapeutic Approach to Cancer and Neurodegenerative Diseases

2016 · Alokta Chakrabarti, Jelena Melesina, et al. · Future Medicinal Chemistry · 105

PDF

MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma

2013 · Marco Lodrini, Ina Oehme, et al. · Nucleic Acids Research · 96

PDF

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

2021 · Klionsky, Daniel J, Abdel-Aziz, Amal Kamal, et al. · Research at the University of Copenhagen (University of Copenhagen) · 95

Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated

2019 · Magalie Géraldy, Michael Morgen, et al. · Journal of Medicinal Chemistry · 92

Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma

2015 · Jonas Ecker, Ina Oehme, et al. · Acta Neuropathologica Communications · 92

PDF

A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat

2011 · Till Milde, Susanne Kleber, et al. · Acta Neuropathologica · 91

PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum

2021 · Karam T. Alhalabi, Damian Stichel, et al. · Acta Neuropathologica · 85

PDF

Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity

2017 · Tino Heimburg, Fiona R. Kolbinger, et al. · Journal of Medicinal Chemistry · 85

The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma

2018 · Juliane L. Buhl, Florian Selt, et al. · Clinical Cancer Research · 84

Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors

2018 · Michael Daskalakis, David Brocks, et al. · Cell Cycle · 81

PDF

HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities

2015 · Emily Koeneke, Olaf Witt, et al. · Cells · 75

Targeting of HDAC8 and investigational inhibitors in neuroblastoma

2009 · Ina Oehme, Hedwig E Deubzer, et al. · Expert Opinion on Investigational Drugs · 75

Works count: 231

Citation count: 14,320

H-index: 41

I10-index: 70